Paradoxical aspects of parkinsonian tremor
暂无分享,去创建一个
[1] M. Guttman. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group. , 1997, Neurology.
[2] J. Dichgans,et al. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings. , 1995, Clinical neuropharmacology.
[3] W. Koller,et al. Adjuvant therapy of parkinsonian tremor. , 1987, Archives of neurology.
[4] Mark Hallett,et al. Parkinson revisited: pathophysiology of motor signs. , 2003, Advances in neurology.
[5] T. Baumann,et al. Tremor control after pallidotomy in patients with Parkinson's disease: correlation with microrecording findings. , 1997, Neurosurgical focus.
[6] M. Guttman. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease , 1997, Neurology.
[7] A L Benabid,et al. Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[8] Seth Love,et al. Unilateral subthalamotomy in the treatment of Parkinson's disease. , 2003, Brain : a journal of neurology.
[9] P. Thompson,et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system , 1992, Neurology.
[10] J. Lieberman,et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. , 1993, The New England journal of medicine.
[11] M. Atay,et al. Impairment, disability, and life satisfaction in Parkinson's disease , 2003, Disability and rehabilitation.
[12] O. Rascol,et al. Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study , 1998, Movement disorders : official journal of the Movement Disorder Society.
[13] S. Gill,et al. Stimulation of the subthalamic region for essential tremor. , 2004, Journal of neurosurgery.
[14] Gordon H Baltuch,et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. , 2003, Journal of neurosurgery.
[15] J. Kulisevsky,et al. Unilateral parkinsonism and stereotyped movements following a right lenticular infarction , 1996, Movement disorders : official journal of the Movement Disorder Society.
[16] P. Hogarth,et al. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. , 2005, Archives of neurology.
[17] J. Dichgans,et al. Tremorlytic activity of budipine in Parkinson's disease. , 1999, Journal of neural transmission. Supplementum.
[18] J. Wit,et al. Catch-Up Growth and Endocrine Changes in Childhood Celiac Disease , 2002, Hormone Research in Paediatrics.
[19] K. Lyons,et al. Long‐term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor , 2001, Movement disorders : official journal of the Movement Disorder Society.
[20] Oliver Pogarell,et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations , 2003, Movement disorders : official journal of the Movement Disorder Society.
[21] W. Pirker,et al. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.
[22] Claude Nahmias,et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study , 2003, Annals of neurology.
[23] R R Tasker,et al. Deep brain stimulation is preferable to thalamotomy for tremor suppression. , 1998, Surgical neurology.
[24] K. Mewes,et al. The Subthalamic Nucleus and Tremor in Parkinson's Disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[25] I. Hamada,et al. Hemorrhagic complication of stereotactic surgery in patients with movement disorders. , 2003, Journal of neurosurgery.
[26] Z. Faulkes,et al. A map of distal leg motor neurons in the thoracic ganglia of four decapod crustacean species. , 1997, Brain, behavior and evolution.
[27] Devin K. Binder,et al. Hemorrhagic Complications of Microelectrode-Guided Deep Brain Stimulation , 2004, Stereotactic and Functional Neurosurgery.
[28] H. Reichmann. Budipine in Parkinson's tremor , 2006, Journal of the Neurological Sciences.
[29] A L Benabid,et al. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation , 1998, Movement disorders : official journal of the Movement Disorder Society.
[30] G. Deuschl,et al. Tremors in Parkinson's Disease: Symptom Analysis and Rating , 1994, Clinical neuropharmacology.
[31] L. Murri,et al. Clozapine in Parkinson's disease tremor , 1997, Neurology.
[32] R. Gross,et al. Clozapine in the treatment of tremor in Parkinson's disease. , 1995, Acta neurologica Scandinavica.
[33] P. Amarenco,et al. Tremor in Parkinson's disease and serotonergic dysfunction An 11 C-WAY 100635 PET study , 2003 .
[34] R. K. Simpson,et al. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor , 1998, Neurology.
[35] R. Elble. Tremor and dopamine agonists , 2002, Neurology.
[36] E. Jansen. Clozapine in the treatment of tremor in Parkinson's disease , 1994, Acta neurologica Scandinavica.
[37] D. Brooks,et al. Long duration asymmetrical postural tremor is likely to predict development of Parkinson’s disease and not essential tremor: clinical follow up study of 13 cases , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[38] J. C. Stoof,et al. Rigidity decreases resting tremor intensity in Parkinson's disease: A [123I]β‐CIT SPECT study in early, nonmedicated patients , 2001, Movement disorders : official journal of the Movement Disorder Society.
[39] A. Schrag,et al. Ropinirole for the treatment of tremor in early Parkinson's disease , 2002, European journal of neurology.
[40] P. Gonzalez-Alegre. Monomelic parkinsonian tremor caused by contralateral substantia nigra stroke. , 2007, Parkinsonism & related disorders.
[41] V. Dhawan,et al. The metabolic anatomy of tremor in Parkinson's disease , 1998, Neurology.
[42] K. Lyons,et al. Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor , 2001, Journal of neurology, neurosurgery, and psychiatry.
[43] D Meier,et al. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study , 2002, Journal of neurology, neurosurgery, and psychiatry.
[44] D. Vaillancourt,et al. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease. , 2004, Brain : a journal of neurology.
[45] G. Canter,et al. A CRITICAL ANALYSIS OF THE EFFECTS OF TRIHEXYPHENIDYL (ARTANE) ON THE COMPONENTS OF THE PARKINSONIAN SYNDROME , 1964, The Journal of nervous and mental disease.
[46] H. Freund,et al. The cerebral oscillatory network of parkinsonian resting tremor. , 2003, Brain : a journal of neurology.
[47] P. Bain,et al. Randomized, double‐blind, 3‐month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor , 2003, Movement disorders : official journal of the Movement Disorder Society.
[48] C. Tanner,et al. Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.
[49] J. Carr. Tremor in Parkinson's disease. , 2002, Parkinsonism & related disorders.
[50] L. J. Doshay. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans. , 1956, Journal of the American Medical Association.
[51] C. Adler,et al. Ropinirole for the treatment of early Parkinson's disease , 1997, Neurology.
[52] P. Krack,et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.
[53] C. Lozza,et al. The Metabolic Substrates of Bradykinesia and Tremor in Uncomplicated Parkinson's Disease , 2002, NeuroImage.
[54] W. Poewe,et al. Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single‐dose challenges , 1999, Movement disorders : official journal of the Movement Disorder Society.
[55] Joffroy Aj. Pathophysiology of parkinsonian tremor. , 1969 .
[56] D. S. Russell,et al. Benign tremulous parkinsonism. , 2006, Archives of neurology.
[57] Tom Robinson,et al. Vascular parkinsonism--an important cause of parkinsonism in older people. , 2005, Age and ageing.
[58] J. Friedman,et al. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease , 1997, Neurology.
[59] I. McKeith,et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.
[60] W. Weiner,et al. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[61] J. Jankovic,et al. A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease , 1994 .
[62] W. Oertel,et al. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease. , 1999, Clinical neuropharmacology.
[63] K. Byth,et al. Postural tremor of Parkinson's disease. , 1994, Clinical neuropharmacology.
[64] J. Krauss,et al. Parkinsonism and rest tremor secondary to supratentorial tumours sparing the basal ganglia , 2005, Acta Neurochirurgica.
[65] T. Ishikawa,et al. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] G. Deuschl,et al. Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study , 2002, Movement disorders : official journal of the Movement Disorder Society.
[67] A. Lees,et al. Anticholinergics for symptomatic management of Parkinson's disease. , 2002, The Cochrane database of systematic reviews.
[68] J. Friedman,et al. Benztropine versus clozapine for the treatment of tremor in Parkinson's disease , 1997, Neurology.
[69] W. Koller,et al. Pharmacologic treatment of parkinsonian tremor. , 1986, Archives of neurology.
[70] K. Marder,et al. Progression of parkinsonian signs in Parkinson disease. , 1999, Archives of neurology.
[71] Adjuvant treatment of Parkinson's disease with budipine: a double-blind trial versus placebo , 1987, Journal of Neurology.
[72] J L Vitek,et al. Role of the thalamus in parkinsonian tremor: evidence from studies in patients and primate models. , 1993, Stereotactic and functional neurosurgery.
[73] H. Przuntek,et al. Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen. , 2002, Archives of neurology.
[74] H. Reichmann,et al. Kinetic tremor in Parkinson’s disease – an underrated symptom , 2006, Journal of Neural Transmission.
[75] M. S. Lee,et al. A patient with a resting tremor and a lacunar infarction at the border between the thalamus and the internal capsule , 1993, Movement disorders : official journal of the Movement Disorder Society.
[76] M. Hennerici,et al. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson’s disease , 2007, Journal of Neurology.
[77] Marwan Hariz,et al. Long‐term efficacy of thalamic deep brain stimulation for tremor: Double‐blind assessments , 2003, Movement disorders : official journal of the Movement Disorder Society.
[78] D. Brooks,et al. Tremor in Parkinson’s disease and serotonergic dysfunction , 2003, Neurology.
[79] Klaus Mewes,et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease , 2003, Annals of neurology.
[80] A. Lieberman,et al. Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study , 1997, Neurology.
[81] R. Uitti,et al. Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. , 2003, Parkinsonism & related disorders.